Results showed that the expressions of IRF4 and c-Myc were down-regulated in PMN-MDSCs from tumor patients compared with those in the controls (P<0.05), but no significant change was detected in expression of IRF4 in M-MDSCs (Figures 7B, C). The gene discussed is IRF4; the disease is neoplasm.